Free Trial

Arcutis Biotherapeutics (ARQT) SEC Filings & 10K Form

Arcutis Biotherapeutics logo
$14.50 +0.39 (+2.73%)
As of 01:36 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Arcutis Biotherapeutics SEC Filings

DateFilerForm TypeView
08/06/2025
2:04 PM
Arcutis Biotherapeutics (Subject)
Topper David Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/05/2025
5:28 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
5:28 PM
Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
5:28 PM
Arcutis Biotherapeutics (Issuer)
Vairavan Latha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
5:28 PM
Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
5:29 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2025
2:38 PM
Arcutis Biotherapeutics (Subject)
Vairavan Latha (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/04/2025
2:40 PM
Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/04/2025
2:42 PM
Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/04/2025
2:43 PM
Arcutis Biotherapeutics (Subject)
Watanabe Todd (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/14/2025
3:02 PM
Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
11:27 AM
Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2025
2:55 PM
Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
9:12 AM
Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2025
3:32 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
1:09 PM
Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2025
4:45 PM
Arcutis Biotherapeutics (Issuer)
Heron Patrick J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2025
3:52 PM
Arcutis Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2025
7:16 PM
Arcutis Biotherapeutics (Issuer)
CHAUDHURI BHASKAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:17 PM
Arcutis Biotherapeutics (Issuer)
Gilbert Halley E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:17 PM
Arcutis Biotherapeutics (Issuer)
Krishnamohan Neha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:17 PM
Arcutis Biotherapeutics (Issuer)
Curran Terrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:17 PM
Arcutis Biotherapeutics (Issuer)
Leonard Keith R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:17 PM
Arcutis Biotherapeutics (Issuer)
Heron Patrick J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:17 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:18 PM
Arcutis Biotherapeutics (Issuer)
LIN SUE-JEAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:53 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2025
7:44 AM
Arcutis Biotherapeutics (Issuer)
Heron Patrick J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
7:25 PM
Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
3:37 PM
Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
4:41 PM
Arcutis Biotherapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SCHEDULE 13G/A
05/09/2025
6:45 PM
Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
4:59 PM
Arcutis Biotherapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
Form SCHEDULE 13G/A
05/08/2025
1:54 PM
Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2025
6:27 PM
Arcutis Biotherapeutics (Issuer)
Vairavan Latha (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/07/2025
6:29 PM
Arcutis Biotherapeutics (Issuer)
Vairavan Latha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:49 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
3:20 PM
Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2025
3:20 PM
Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2025
4:15 PM
Arcutis Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2025
3:21 PM
Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the September 1st funding windo
04/03/2025
3:21 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
3:41 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:20 PM
Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
5:27 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
3:19 PM
Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
4:10 PM
Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
6:43 PM
Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:43 PM
Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:43 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:43 PM
Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:43 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:44 PM
Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:46 PM
Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
3:47 PM
Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
4:39 PM
Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
4:36 PM
Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
4:38 PM
Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:50 PM
Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
3:13 PM
Arcutis Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/04/2025
7:00 PM
Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:00 PM
Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:00 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:01 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:01 PM
Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
5:03 PM
Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
5:04 PM
Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
5:01 PM
Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
5:02 PM
Arcutis Biotherapeutics (Subject)
Edwards Larry Todd (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
4:10 PM
Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
6:33 AM
Arcutis Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
4:26 PM
Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/31/2024
5:13 PM
Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:19 PM
Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/23/2024
6:22 PM
Arcutis Biotherapeutics (Issuer)
Watanabe Todd Franklin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:02 PM
Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
3:25 PM
Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
3:21 PM
Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
6:52 PM
Arcutis Biotherapeutics (Issuer)
Matsuda Masaru (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
3:25 PM
Arcutis Biotherapeutics (Subject)
Matsuda Masaru (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
6:04 PM
Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:31 PM
Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
6:50 PM
Arcutis Biotherapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/13/2024
5:45 PM
Arcutis Biotherapeutics (Issuer)
Curran Terrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:30 PM
Arcutis Biotherapeutics (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G/A
11/12/2024
10:34 AM
Arcutis Biotherapeutics (Subject)
Curran Terrie (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
3:07 PM
Arcutis Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2024
3:41 PM
Arcutis Biotherapeutics (Subject)
Watanabe Todd Franklin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
1:51 PM
Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
2:24 PM
Arcutis Biotherapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G/A
10/03/2024
3:55 PM
Arcutis Biotherapeutics (Issuer)
Edwards Larry Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the September 1st funding windo
10/03/2024
3:55 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
2:32 PM
Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/25/2024
8:42 PM
Arcutis Biotherapeutics (Issuer)
Topper David Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2024
2:51 PM
Arcutis Biotherapeutics (Subject)
Topper David Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
4:56 PM
Arcutis Biotherapeutics (Issuer)
Welgus Howard G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
12:37 PM
Arcutis Biotherapeutics (Subject)
Welgus Howard G. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
3:39 PM
Arcutis Biotherapeutics (Issuer)
Burnett Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
4:43 PM
Arcutis Biotherapeutics (Subject)
Burnett Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ARQT) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners